Cargando…

Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics

BACKGROUND: Quantifying physical activity in chronic obstructive pulmonary disease (COPD) is important as physical inactivity is related to poor health outcomes. This study analyzed the relationship between patients’ self-reported daily walking time and relevant characteristics related to COPD sever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramon, Maria A, Esquinas, Cristina, Barrecheguren, Miriam, Pleguezuelos, Eulogio, Molina, Jesús, Quintano, José A, Roman-Rodríguez, Miguel, Naberan, Karlos, Llor, Carl, Roncero, Carlos, Miravitlles, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402919/ https://www.ncbi.nlm.nih.gov/pubmed/28458527 http://dx.doi.org/10.2147/COPD.S128234

Ejemplares similares

Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life
por: Miravitlles, Marc, et al.
Publicado: (2010)

Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
por: Núñez, Alexa, et al.
Publicado: (2018)

Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores
por: Miravitlles, Marc, et al.
Publicado: (2018)

Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2015)

COPD heterogeneity: implications for management
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

What have we learned from observational studies and clinical trials of mild to moderate COPD?
por: Barrecheguren, Miriam, et al.
Publicado: (2018)

Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care
por: Barrecheguren, Miriam, et al.
Publicado: (2018)

Cognitive status among patients with chronic obstructive pulmonary disease
por: Roncero, Carlos, et al.
Publicado: (2016)

Frequency and Associated Factors of Suicidal Ideation in Patients with Chronic Obstructive Pulmonary Disease
por: Roncero, Carlos, et al.
Publicado: (2022)

Practice and knowledge about diagnosis and treatment of alpha-1 antitrypsin deficiency in Spain and Portugal
por: Esquinas, Cristina, et al.
Publicado: (2016)

Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Monteagudo, Mònica, et al.
Publicado: (2021)

A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)
por: Miravitlles, Marc, et al.
Publicado: (2013)

The Experience of COPD Patients in Lockdown Due to the COVID-19 Pandemic
por: Pleguezuelos, Eulogio, et al.
Publicado: (2020)

Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
por: Belmonte, Irene, et al.
Publicado: (2016)

Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis
por: Martinez-García, Miguel Angel, et al.
Publicado: (2022)

The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD
por: Miravitlles, Marc, et al.
Publicado: (2015)

Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease
por: Soler-Cataluña, Juan José, et al.
Publicado: (2022)

How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies
por: Pleguezuelos, Eulogio, et al.
Publicado: (2018)

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)
por: Esquinas, Cristina, et al.
Publicado: (2018)

Nordic Walking improves daily physical activities in COPD: a randomised controlled trial
por: Breyer, Marie-Kathrin, et al.
Publicado: (2010)

Respuesta de los autores
por: Bruscas Alijarde, M. José, et al.
Publicado: (2015)

Estudio ARAPOC: prevalencia de síntomas respiratorios y enfermedad obstructiva crónica en población general()
por: Bruscas Alijarde, M. José, et al.
Publicado: (2015)

New variants of alpha-1-antitrypsin: structural simulations and clinical expression
por: Gonzalez, Angel, et al.
Publicado: (2022)

Easy to Perform Physical Performance Tests to Identify COPD Patients with Low Physical Activity in Clinical Practice
por: Matkovic, Zinka, et al.
Publicado: (2020)

Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency
por: Esquinas, Cristina, et al.
Publicado: (2017)

Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency
por: Pons, Mònica, et al.
Publicado: (2021)

Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma–COPD overlap (ACO): a scoping review protocol
por: Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof, et al.
Publicado: (2017)

Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2013)

Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease
por: Nuñez, Alexa, et al.
Publicado: (2020)

Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique
por: Blanco, Ignacio, et al.
Publicado: (2017)

Basic assessment of chronic cough in primary care and referral pathways of patients to different specialists
por: Domingo, Christian, et al.
Publicado: (2023)

Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory
por: Belmonte, Irene, et al.
Publicado: (2020)

Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Núñez, Alexa, et al.
Publicado: (2021)

Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Núñez, Alexa, et al.
Publicado: (2021)

Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
por: Miravitlles, Marc, et al.
Publicado: (2020)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Understanding the impact of symptoms on the burden of COPD
por: Miravitlles, Marc, et al.
Publicado: (2017)

Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2018)

Development and Relevance of Hypercapnia in COPD
por: Dave, Chirag, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4daqee8oled8h88iui002mj5ek